Whats truly interesting is . If this was a mining share and the mine had the potential to extract a portion of an ore load of $100 000 000.00 per year it definitely wouldn’t be a 2.6c share. Yet with relatively low overheads and the current rock samples showing great potential nobody seems to be wanting to speculate on the future.
I would have expected that an announcement that describes access to the mother load by May would have had the SP moving, but alas we are hovering . A re rate is coming, but I can’t seem to figure out why it’s not happening now.
Perhaps by next quarter the enthusiasm may increase.
I wonder if the announcement of May by PD is a date that he has been given by FDA or a speculation of 150 day average.
With all the pre submissions and back and forth correspondence, I was genuinely confident of a quicker than average approval. I had late March early April as my scenario of approval. Let’s face it, it is a medical device, but only really a Class 1. Nobody dies with a misdiagnosis from painchek. It is merely an objective tool to save time and paper, and allowing users to make informed decisions on forward treatment, with data collected in the process.
I can’t see it not being approved as it is being used already incident free and with positive outcomes.
And I can’t see it taking that long to be approved, All boxes are checked, all ethical, clinical studies support its use. What is the hold up. Get on with it FDA it’s not rocket science.
Good luck Holders.
2025 as predicted by Fatt is heating up for a big year. I agree but have been premature several times now and patience is all that required.
I think all those whom have done their research can see that this has the potential to make some serious money .
DYOR.
Add to My Watchlist
What is My Watchlist?
